Exozymes (NASDAQ:EXOZ) Posts Quarterly Earnings Results

Exozymes (NASDAQ:EXOZ) released its quarterly earnings results on Monday. The company reported ($0.22) earnings per share (EPS) for the quarter, Zacks reports.

Exozymes Stock Up 4.5%

NASDAQ:EXOZ traded up $0.58 during trading hours on Monday, reaching $13.59. 35,248 shares of the stock were exchanged, compared to its average volume of 19,574. Exozymes has a twelve month low of $8.50 and a twelve month high of $23.99. The company’s 50 day simple moving average is $12.14.

Exozymes Company Profile

eXoZymes, Inc is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.